Introduction
Shiga-toxigenic Escherichia coli (STEC), also called enterohemorrhagic E. coli (EHEC) or Verotoxigenic E. coli (VTEC) is a type of diarrhea-producing E. coli more common in developed countries than in developing countries. More severe cases are characterized by bloody diarrhea and some patients go on to develop severe systemic complications such as hemolytic-uremic syndrome (HUS) and encephalopathy. STEC is genetically and evolutionarily related to enteropathogenic E. coli (7) , an E. coli pathotype known for causing long-lasting watery diarrhea in children in developing countries.
Zinc has been shown to reduce the duration and severity of acute diarrhea in children in field trials on several continents (1, 24) . In earlier decades, these beneficial effects of zinc were usually attributed to the correction of zinc deficiency (29) , which is unfortunately still seen in poor malnourished children. In more recent years, however, studies have shown that zinc can be beneficial against diarrhea even in patients without zinc deficiency (2, 21) .
In a previous study, we showed that zinc reduced the expression of several important virulence factors in EPEC and reduced EPEC-induced intestinal damage and fluid secretion in ligated rabbit intestinal loops in vivo (5) .
Since the locus of enterocyte effacement (LEE) is regulated in a similar way in STEC as in EPEC, we investigated whether zinc had any similar protective properties against STEC virulence factors in the LEE. We also tested whether the inhibitory effects of zinc on the expression of EHEC secreted protein A (EspA) were dependent on Ler, the LEE encoded regulator, as they were in EPEC. Next we tested the ability of zinc to inhibit production of Shiga toxins, which are not present in EPEC but are the hallmark of STEC strains. Zinc inhibited basal as well as antibiotic-induced expression of both Stx1 and Stx2 in a variety of STEC strains, with > 90 % inhibition of Stx achievable with zinc concentrations of 0.4 to 0.5 mM. In vivo, zinc protected rabbit intestinal loops from STEC-induced histological damage, reduced STEC adherence to epithelium, and reduced Stx production in loop fluids in vivo. However, STEC bacterial numbers were similar in zinc-treated and control loops.
The anti-virulence effects of zinc extend to STEC as well as EPEC and are independent of the zinc nutritional status of the host. Further work is needed to understand the mechanism of Stx inhibition by zinc and to better define the protective dose of zinc in humans. In addition, we on October 2, 2017 by guest http://iai.asm.org/ Downloaded from wonder if zinc's inhibitory effects are limited to EPEC and STEC, or if they extend to other bacterial enteropathogens as well.
Materials and Methods
Bacterial strains used. Bacterial strains used are listed in Table 1 . Bacteria were grown overnight in LB broth at 37 º with 300 rpm shaking, then subcultured into DMEM medium. In this report, when bacteria were subcultured in "DMEM" this refers to DMEM/F12 medium supplemented with 18 mM NaHCO 3 and 25 mM HEPES, pH 7.4, but without serum or antibiotics. DMEM/F12 medium contains 1.5 µM zinc The ∆ler mutant of EDL933, CB49, was a gift from Dr. Alfredo Torres, Univ. of Texas Medical Branch, Galveston, TX.
Materials. The following reagents were obtained from Sigma-Aldrich Chemicals: zinc acetate, NiCl 2 , MnCl 2 , CuSO 4 , Ga(NO 3 ) 3 . FeSO 4 was from MP Biomedicals, Irvine, Calif.
Cell culture. HeLa cells were grown in DMEM/F12 medium supplemented with 7.5% fetal bovine serum (Gibco/Invitrogen, Grand Island, NY), 18 mM NaHCO 3 , 20 µg/ml vancomycin, and 15 µg/ml gentamicin as previously described (4) . According to the Gibco/ Invitrogen catalog, the amount of zinc in DMEM/F-12 medium, not including serum, is 1.5 µM.
Bacteriophage Transduction of Rabbit EPEC Strains to Produce Stx-producing rabbit-adapted E. coli strains. The methods used to generate strain RDEC-H19A, in which bacteria carrying the antibiotic resistance tagged Stx1 phage from an O26 strain were co-cultured with the recipient RDEC-1 strain, have been previously described (22) . Similar methods were used to select strain E22-stx2. Briefly, O157:H7 strain 86-24 (Stx2 only) was used as the phage source. A 1.5 kb kanamycin resistance marker was introduced 27 kb downstream from the Stx-2B coding sequence, and between predicted open reading frames. This insertion did not affect Stx-2 production (as determined by cytotoxicity analysis in vitro of cell lysates) and a lysogenic tagged strain was capable of being induced to produce entire phage particles. Following co-culture with the recipient O103 E22 strain, kanamycin resistant isolates were selected which had acquired the Stx2 phage as confirmed by PCR, and which were able to produce Stx without and with antibiotic induction. One such isolate was named E22-Stx2. Rabbits inoculated with this Stx2-producing lysogenic REPEC strain developed more severe histological lesions and inflammation as compared with those inoculated with the isogeneic non-toxin producing wild type strain E22.
on October 2, 2017 by guest http://iai.asm.org/ Downloaded from Adherence Assay. Quantitative adherence assays were performed in duplicate or triplicate wells of HeLa cells grown in collagen-coated 24 well plates. HeLa cells were used at 90% confluency; cells were rinsed and changed into 0.25 ml per well of antibiotic-free DMEM medium, then infected with STEC at a multiplicity of infection (MOI) of 100:1. STEC bacteria were grown overnight in LB broth, then subcultured for 2 h in DMEM medium. To enhance adherence, STEC bacteria were centrifuged onto the HeLa cells at 500 g for 5 min at room temperature, then allowed to adhere for 2.5 h at 37 º C in a 5% CO 2 atmosphere. After 2.5 h of STEC adherence, the monolayers were washed twice with sterile phosphate-buffered saline (PBS) to remove unbound bacteria, then the monolayers were solubilized in 0.1 % Triton X-100 detergent in water. The Triton extracts were subjected to serial dilution and were spread on LB agar plates in duplicate and the number of colonies counted. Adherence was calculated as parts per thousand (º/ oo ) of the input inoculum.
Enzyme Immunoassay (EIA) for Shiga toxin protein. Shiga toxin protein was measured by EIA using the Premier EHEC EIA kit from Meridian Bioscience, Cincinnati, OH, which measures Stx1 and Stx2. Since different STEC strains produced different amounts of Shiga toxin, required different concentrations of antibiotics for induction of Stx, and so on, the optimal conditions for growth and EIA detection had to be determined by trial-and-error. The optimal antibiotic concentrations, culture duration, and dilutions of supernatant needed for successful Stx EIA detection for various STEC strains are summarized in Table 2 . Bacterial culture supernatants were filter sterilized prior to Stx measurement by EIA; therefore, any toxin trapped in the periplasmic space, often a substantial proportion for Stx1 (31), would not be measured in our assay.
Analysis of RNA expression by reverse transcription and quantitative real-time PCR.
Quantitative real-time PCR was carried out as described previously (5, 6) . Primers for stx1 were those described by Jinneman et al. (11) , while those for stx2, STEC espA, and the normalizing gene gnd were from the methods of Rashid et al. (18) . Primers for measuring expression of espA and espB in rabbit EPEC strain E22 were as reported (6) .
Normalizing genes for analysis of expression were rrsB, using the primers reported by Leverton & Kaper (14) and gnd as reported by Rashid et al. (18) . Calculations of normalized expression using the two different normalizing genes gave quite similar results. Zinc oxide (ZnO) is known to be less ionized and less bioavailable that the other 2 zinc salts.
Since the 3 salts have different molecular weights, we adjusted the oral dose to achieve equal, 10 mg doses of elemental zinc and administered each zinc salt by orogastric tube to rabbits once daily for 3 consecutive days. Intestinal contents were collected from the small intestine, proximal cecum, mid-cecum, and large intestine. Rabbits used in this experiment had an average body weight of 2.4 kg, yielding a zinc dose of 4.1 mg/kg (mg elemental zinc per kg body weight).
Rabbits were not surgically altered, nor were they infected with STEC. Zinc content of the samples was determined at Michigan State University, a national reference laboratory, by
Inductively Coupled Plasma Mass Spectrometry (ICPMS). In addition to samples collected at the time of euthanasia, fecal pellets were collected daily, and the rabbits were killed humanely on the evening of the third day. Fecal pellets collected on the portion of day 3 were insufficient for Based on normal rabbit chow consumption of 50 to 70 g/day, this means even the control rabbits were receiving 3 to 4 mg of elemental zinc daily via their food.
Results
Initially we tested whether zinc had any effect on the adherence of human STEC strains to cultured cells in vitro. Fig. 1 shows that 0.2 to 0.4 mM zinc almost completely abolished STEC adherence to HeLa cells in a short-term adherence assay. The molecular basis for STEC adherence to host cells is less well understood than for EPEC, with different laboratories reporting many putative adhesins, including intimin, EspA, H7 flagellae, outer membrane protein A (OmpA), long polar fimbriae, and hemolysin to name just a few (16, 18, 22, 23, 26, 27) .
Therefore, while the inhibition of STEC adherence by zinc is important, it does not immediately point to a molecular mechanism.
Zinc inhibited expression of the EPEC secreted proteins EspA and EspB in strain E2348/69, so we tested if zinc also inhibited expression of the esp genes in STEC strain EDL933. Zinc did inhibit esp expression in EDL933 (see Fig. 2A for espA). In EPEC, the inhibitory effect of zinc on the Esps showed an unexpected dependence on the LEE-encoded regulator, Ler, and was abolished in the ∆ler mutant. We compared the effect of zinc on the ∆ler mutant of EDL933, designated CB49, with its effect on the wild-type parental strain. Fig. 2A and Fig. 2B show that the inhibitory effect of zinc was lost in the ∆ler mutant of EDL933, just as it was in the EPEC ler mutant. To try to extend these findings even more, we compared the effect of zinc on the wild-type rabbit EPEC strain E22 with its effect on the ∆ler mutant of E22, strain ECB159. As with human EPEC and STEC, the inhibitory effect of zinc on espA and espB was lost in the ∆ler mutant of E22 ( . Pilot experiments showed that ciprofloxacin induced Stx toxin production in all strains tested, so ciprofloxacin was used in tests of antibiotic-induced toxin production. Fig. 3 shows that zinc was able to inhibit ciprofloxacin-induced toxin production in strain Popeye-1 In order to test the effect of zinc in a rabbit intestinal model of STEC infection, two rabbit STEC strains were also tested for susceptibility to inhibition by zinc. Fig. 3D shows that zinc inhibited Stx2 production by rabbit strain E22-stx2. Toxin production from rabbit strain RDEC-H19A was also inhibited by zinc (data not shown).
In addition to its ability to inhibit ciprofloxacin-induced Stx, zinc also inhibited trimethoprim-induced Stx toxin production and release (Fig. 3E) . Zinc also inhibited H 2 O 2 -induced Stx production as well (Fig. 3F ). H 2 O 2 has been implicated as an inducer of Stx toxin production in vivo in the absence of antibiotics (28) . Fig. 3 showed that zinc was able to inhibit Stx production from a variety of different STEC strains, including strains that produce Stx1, Stx2, and both toxins; furthermore, zinc inhibited basal as well as antibiotic-induced toxin production.
Because of the promising results found using Stx toxin protein measurements, we also measured stx RNA by qRT-PCR. Using the same strain, we also compared the inhibitory ability of zinc with that of other divalent metals and gallium nitrate at 0.3 mM concentration (Fig. 4B) . Gallium was tested because of its position adjacent to zinc on the periodic table and because Kaneko et al. reported that gallium has strong antivirulence and anti-biofilm activity against Pseudomonas aeruginosa (12) . Zinc and nickel chloride were the most inhibitory, followed by copper, then manganese and gallium. In contrast, addition of FeSO 4 actually stimulated stx2 RNA even more than that produced by ciprofloxacin alone. Although nickel strongly inhibited stx2 expression, nickel is also much more toxic to humans than is zinc (Table 3 ). In EPEC, nickel also had a paradoxical stimulatory effect on expression of the bundle-forming pilus and on the EPEC secreted proteins (5), and the adherence-enhancing ability of nickel was confirmed in another E. coli strain (17).
Because of these two undesirable features of nickel (increased toxicity and enhancement of pathogen adherence), we believe zinc is divalent metal with the best combination of desirable properties: inhibition of virulence expression in the pathogen and low toxicity toward the host. In addition to the parameters mentioned, zinc also inhibited the amount of Stx toxin that accumulated in the loops infected with rabbit STEC (Fig. 5D) . In contrast to the inhibitory Fig. 5H and 5I) show histology that is difficult to distinguish from normal, uninfected ileum (uninfected not shown), with normal slender villi and almost no adherent pathogenic E.
coli.
In our previous work with zinc on EPEC, and in the present study of zinc on STEC, we observed that fairly high concentrations of zinc, in the 0.1 to 0.5 mM range, were required to inhibit virulence. We were unsure if such high concentrations of zinc were achievable in the lumen of the gastrointestinal tract. To determine what concentrations of zinc were produced in response to oral zinc, we measured zinc in various segments of the rabbit gastrointestinal (GI) tract after orogastric adminstration of three different zinc salts: zinc acetate, zinc sulfate, and zinc oxide.
As shown in Fig. 6A , the 10 mg dose of zinc resulted in levels of zinc in the intestinal tract that were significantly higher than those in the control, non-zinc-treated rabbits. Zinc levels we measured in intestinal and cecal lumen were in the 0.3 to 0.4 mM range for both of the more bioavailable zinc salts (acetate and sulfate), ranges that we have shown are inhibitory for both EPEC and STEC virulence. In the fecal pellets, zinc levels were even higher, reaching 0.5 to 0.6 mM (Fig. 6B) ; higher levels are expected due to reabsorption of water from intestinal contents during passage through the colon. Furthermore, increased levels of zinc were observed in the fecal pellets after just 1 day of administration, showing that zinc supplements would not have to be given for a prolonged period to achieve protective levels in the distal GI tract. In contrast to the large, ~3-fold increase in zinc levels in the intestinal and fecal contents, zinc levels in rabbit plasma increased only 28 % in the zinc acetate-and zinc sulfate-supplemented groups, compared to control rabbits. This finding is in accord with the nutrition literature (15) in that the ability of the upper GI tract to absorb zinc is limited, like its ability to absorb iron. High doses of oral zinc can apparently exceed the absorptive ability of the upper GI tract and thereby reach therapeutic concentrations in the lower GI tract where EPEC and STEC adhere and cause disease. The doses of zinc required for this latter purpose well exceed the amounts of zinc needed to maintain normal zinc nutritional status, so that high-dose zinc should be viewed as acting more like a drug and less as a nutrient in this context.
Discussion
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Our previous work showed that zinc blocked the production of virulence factors in EPEC, with strong inhibition by zinc of the production of the bundle-forming pilus, several EPEC secreted proteins (Esps), intimin, and Tir. Since EPEC is considered the evolutionary progenitor of most STEC strains (7, 30), we wondered if zinc's inhibitory effects extended to STEC virulence factors as well.
As in EPEC, zinc inhibited expression of the Esps in STEC (Fig. 2) , which is not surprising considering the similarity in the operons of the locus for enterocyte effacement (LEE)
between EPEC and STEC, including the regulation of the LEE4 operon which encodes the Esps.
In our previous work, we noticed that the inhibitory effects of zinc were abolished in an isogenic strain with a deletion mutation in ler, the LEE-encoded regulator. Here we show again that in the ∆ler mutant of STEC strain EDL933, and in the ∆ler mutant of rabbit EPEC E22, zinc's inhibitory effects on espA and espB were lost ( (Fig. 2F) . Therefore, although the principle of parsimony would make it desirable to postulate a single, unifying target for zinc action, our current data forces us to hypothesize that there are at least two independent targets for zinc in STEC: one which involves Ler, and a separate Ler-independent target that mediates inhibition of Stx. Zinc and other divalent metals have been noted to be able to inhibit protein and RNA synthesis at concentrations similar to those used in our study (0.1 to 0.3 mM) (3, 8 ). There appears to be some general ability of divalent metals (zinc, nickel, copper, cobalt, etc.) to inhibit E. coli growth and protein synthesis, but among this group of metals zinc appears to stand out as the most potent inhibitor of EPEC and STEC virulence factor expression (Figs. 3A, 4B , and Ref.
5).
In non-surgically altered rabbits, zinc levels in GI tract contents achieved levels in the range (0.3 to 0.5 mM) that our in vitro experiments showed were sufficient to inhibit adherence, Esp expression, and Stx production. The data in Fig. 6 , however, were obtained in rabbits which
were not infected with EPEC or STEC. The zinc levels achieved in the presence of active infection could be different from those we measured in uninfected rabbits. EPEC is known to induce a malabsorptive state in humans and animals (20, 25) , so it is possible that zinc absorption would be reduced during infection and that higher amounts of zinc would therefore reach the ileum, cecum, and colon. On the other hand, zinc concentrations could be reduced by the dilutional effect of diarrheal fluid secretion. Determining the concentrations of zinc achievable in the intestinal lumen in the presence of active infection is therefore a goal for future research.
For many years there has been a strong presumption in the nutrition literature that the beneficial effects of zinc supplementation in infectious diseases, including infectious diarrhea, were due to correction of a pre-existing zinc deficiency. This view has unfortunately persisted despite that fact that field studies of zinc have shown benefits even in subsets of children with normal plasma zinc levels (21) . That "zinc deficiency" view has led to the assumption that zinc supplements would offer no benefit in diarrheal illness in previously well-nourished subjects.
The present study, our previous work (5), and the work of others (13) strengthens our belief that zinc, by acting directly against pathogen virulence, could be therapeutic even in humans and animals with completely normal zinc nutritional status. The doses of zinc required for this protective effect are supra-physiologic, meaning that zinc is acting in a drug-like fashion. min to enhance adherence. Adherence was allowed to proceed for 2.5 h, then adherent bacteria were measured by dilution and plate counts as described in "Materials and Methods." STEC bacteria were only exposed to the zinc during the 2.5 h adherence period itself, i.e., no preincubation with zinc. Adherence was calculated as parts per thousand (º/ oo ) of the input inoculum. Adherence was significantly reduced at concentrations of zinc of 0.1 mM and greater for both strains (p <0.05 by ANOVA, using Tukey-Kramer post-test for multiple comparisons). 
